40+ years of excellence in custom synthesis and bioconjugation services.
Calculators, design tools, and educational content to support your research.
Dendrimer and brancher-modified oligonucleotides for multivalent binding, signal amplification, high payload density, surface presentation, nanoparticle assembly and advanced oligo conjugation workflows.
Bio-Synthesis provides custom dendrimer and brancher oligonucleotide modification services from design review through synthesis, conjugation, purification, analytical QC and documentation.
Our team can help build Doubler, Trebler, 5-Me-dC brancher, PAMAM and Bis-MPA dendron oligonucleotides for projects requiring controlled valency, high payload density, multivalent binding, PEG spacing or staged conjugation.
Best-fit projects: signal-amplified probes, multivalent aptamers, high-density surface immobilization, nanoparticle assembly, multi-label oligos and multifunctional oligo conjugates.
Bio-Synthesis capabilities: custom brancher placement, dendron conjugation, multi-label payloads, PEG/TEG spacing, HPLC/SEC purification, ESI/MALDI-MS, UV-Vis loading analysis and custom release documentation.
Key design levers: valency, branch placement, spacer length, hydrophilicity, payload size, orthogonal handles and QC method.
Bio-Synthesis offers a range of brancher and dendrimer modification technologies to support multivalent binding, signal amplification, payload delivery and advanced oligonucleotide conjugation. Explore the options below to identify the most appropriate architecture for your application.
The symmetric doubler produces two branches with the same oligo sequence, supporting compact bivalent designs and two-arm labeling strategies.
You need two arms, dual labels, bivalent binding, or a compact brancher with less steric burden.
Start at the 5′ or 3′ terminus to minimize Tm impact before moving to internal branch points.
Trebler branchers create three arms for stronger signal amplification, higher ligand display or multi-handle oligonucleotide constructs.
You need three reporters, multivalent ligand display, or a compact alternative to larger dendrons.
More arms can increase self-quenching, aggregation or steric clash. Use PEG/TEG spacing when payloads are bulky or hydrophobic.
PAMAM and Bis-MPA dendrons provide controlled higher-order valency, typically used when payload density, surface presentation or delivery architecture matters more than compactness.
You need higher payload density, nanoparticle or surface presentation, drug/ligand loading, or staged multifunctional conjugation.
High-MW dendrimer conjugates may require SEC, diafiltration and loading analysis in addition to HPLC and MS.
Oligonucleotide dendrimers can be assembled by growing outward from a core or inward from the periphery. Branching cycles control size, generation, terminal group density and final properties.
Growth proceeds from core to periphery; useful for building increasing valency in controlled generations.
Growth proceeds from periphery toward the center; useful for assembling defined dendrons before final attachment.
Dendrimeric modifiers can be built onto conventional oligos or directly on solid support, with 3′ or 5′ synthesis chemistry.
Dendrimeric oligonucleotides use defined dendritic scaffolds to control valency, surface functionality and payload density. Bio-Synthesis can support brancher-modified oligos, dendron-oligo conjugates and higher-valency dendrimeric oligonucleotide constructs for research and development applications.
Generation number describes how many branching cycles are present. Higher generations generally increase terminal group count and payload capacity, but may also increase steric burden, purification complexity and analytical requirements.
High amine density and broad conjugation flexibility for multivalent oligo, ligand and payload display.
Controlled polyester dendron architecture often considered for biodegradable or biocompatible designs.
Dense polypropyleneimine scaffolds for high surface functionality and multivalent conjugation strategies.
Peptide-based dendritic scaffolds for biocompatible multivalent oligonucleotide and ligand presentation.
Bio-Synthesis provides a broad range of brancher and dendrimer modification options for custom oligonucleotide projects. Additional architectures, spacers and dendron configurations may be evaluated based on project requirements.
Successful dendrimer and brancher oligonucleotide designs require careful consideration of branch placement, linker selection, payload compatibility and analytical strategy. The following guidelines can help support project planning and manufacturing review.
These architectures are most valuable when one linear oligo cannot carry enough binding sites, reporters, ligands or payload.
Multiple reporters, redox tags, dyes or ligands can be displayed from a single oligo backbone to improve sensitivity, avidity or surface density.
Aptamer Multimerization Doubler, Trebler or dendron nodes can raise apparent affinity through multivalent interactions.
High-Density Immobilization Terminal branch nodes can improve packing on electrodes, microarrays or sensor surfaces.
Drug / Ligand Delivery Bis-MPA or PAMAM dendrons can increase payload per oligo strand with controlled valency.
Nanoparticle Assembly Branching supports DNA/RNA nanoparticle presentation and controlled surface valency.
Dendrimer-oligonucleotide constructs are useful when a project requires multiple oligonucleotide domains, dense ligand presentation, controlled payload loading or multifunctional conjugation from a defined scaffold.
Dendrimeric scaffolds can support multivalent display, targeting ligands or delivery-oriented oligo conjugates.
Aptamer dimers, trimers and higher-valency systems can be designed to improve apparent avidity or receptor engagement.
Branchers or dendrons can increase payload density while preserving defined oligonucleotide architecture.
Multiple dyes, reporters or affinity handles can be displayed to increase local signal density.
Dendrimeric oligos can provide controlled surface valency for nanomaterial and biosensor interfaces.
Ligands, aptamers and oligonucleotide domains can be combined for targeted delivery research workflows.
Multivalent spacing can support dense presentation on arrays, electrodes and solid supports.
Targeting, capture, reporting and payload functions can be combined in one dendritic architecture.
Different brancher and dendrimer architectures are optimized for different applications. The matrix below provides general guidance for selecting an appropriate modification strategy based on project objectives.
Why it helps: multiple reporters per oligo improve signal density.Typical setup: Trebler, dendron, multi-dye payload, HPLC + UV-Vis loading.
Why it helps: multivalency can improve apparent avidity.Typical setup: terminal brancher, PEG spacing, binding assay or Tm check.
Why it helps: higher payload per strand with controlled presentation.Typical setup: PAMAM or Bis-MPA dendron, orthogonal handles, SEC + loading analysis.
Why it helps: improves local ligand density on sensors or arrays. Typical setup: terminal brancher, thiol/amine/biotin, PEG spacer, surface QC.
Why it helps: combines targeting, reporting and capture on one oligo. Typical setup: staged conjugation, orthogonal handles, HPLC/SEC + MS review.
Dendrimer and brancher-modified oligonucleotides may require specialized purification and analytical characterization to ensure product identity, payload loading, purity and overall performance.
Recommended release may include HPLC, RP/IEX, SEC, ESI-MS, MALDI-TOF, UV-Vis loading analysis, optional CE, buffer exchange and custom documentation depending on construct complexity.
HPLC and/or SEC for high purity; removes truncates, free dyes and excess dendrons.
ESI-MS and MALDI-TOF where compatible; expect broader envelopes for dendrimer constructs.
UV-Vis for dyes or ligands; report average loading and counter-ion details when needed.
Lyophilized tubes, 96-well plates, barcoded vials, buffer exchange and OEM/private-label packaging.
50–100 nmol development lots to multi-mg or gram-scale programs.
RUO, GLP or cGMP documentation can be discussed based on project stage.
Store lyophilized at 4 °C short-term or −20 °C long-term; protect light-sensitive labels.
Explore related Bio-Synthesis services for oligonucleotide conjugation, PEGylation, nanoparticle functionalization, surface immobilization, analytical characterization, branched oligo synthesis and custom RNA synthesis.
→
Providing the following project information can help accelerate feasibility review, quotation and production planning.
Oligo sequence and backbone
Desired valency or generation
Brancher/dendron type
5′, 3′ or internal placement
Spacer/linker preference
Dye, ligand, drug or tag payload
Scale and delivery format
Purification and QC needs
Highly branched or high-payload constructs should be reviewed for steric burden, hydrophobicity, aggregation risk, solubility, mass-confirmation feasibility and purification strategy before final quote approval.
For recurring supply, OEM/private-label, plate formatting, barcoding, GLP-style documentation or cGMP-aligned programs, include packaging and documentation requirements up front.
Scientific disclaimer: Final brancher, dendron and payload design must be reviewed for manufacturability, analytical compatibility and intended-use requirements.
Quality management system
Medical-device quality framework
Custom synthesis experience
U.S. production support
Program-dependent support
Valency, placement, spacer strategy, hydrophilicity, payload compatibility and staged conjugation planning.
HPLC, SEC, ESI-/MALDI-MS, UV-Vis loading, CoA and custom documentation.
Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.